Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity
Angewandte Chemie International Edition · 27.07.2026 · 65 (31)
DOI: 10.1002/anie.5724301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.05.2026. Verfasst von Shuangbo Dang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, People's Republic of…. Hauptthemen laut MEDLINE: Immunity, Cellular, Immunity, Humoral, Nanovaccines, Vaccines, DNA. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation General Program, Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund Project.
Abstract (Originalsprache)
Subunit vaccines offer safety and precision but require adjuvants to overcome weak immunogenicity, particularly for the induction of cellular immunity. Herein, we develop a manganese pyrophosphate mineralized DNA bi‐adjuvant‐based subunit vaccine platform via biomineralization, which demonstrated the capability to elicit robust antigen‐specific cellular immune responses. The Mn/CpG bi‐adjuvant modulated the balance between Th1 and Th2 immune responses. More importantly, the synergistic activation of Toll‐like receptor 9‐like (TLR9) signaling pathways by CpG and cGAS‐STING pathways mediated by Mn(II) ions robustly enhanced cellular immunity, which was a magnitude of enhancement over commercial aluminum‐based adjuvants both in vitro and in vivo. Furthermore, the mechanistic studies revealed that the Mn(II)‐based nanoadjuvant effectively promoted Th1‐biased cellular immune response, as evidenced by an elevated IgG2a/IgG1 ratio and enhanced Th1‐associated cytokine secretion, alongside a potential reduction in regulatory T cell activity. These insights established critical design principles essential for the development of next‐generation manganese‐derived adjuvant systems, thereby advancing the frontiers of vaccinology and immunology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, People's Republic of China.
- Immunological Materials Research Group 1, National Vaccine and Serum Institute (NVSI), Beijing, People's Republic of China.
- National Engineering Center for New Vaccine Research, Beijing, People's Republic of China.
- Immunological Evaluation Unit, National Vaccine and Serum Institute (NVSI), Beijing, People's Republic of China.
- The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation General Program
- Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund Project
- Fundamental Research Funds for the Central Universities
- Peking University Third Hospital Fund for Interdisciplinary Research
Zitieren
APA
Dang, S., Sun, Y., Chen, L., Dong, Y., Han, Z., Hou, J., Wang, X., Kang, Z., Liu, Z., Wang, Z., Li, Q., Ren, J., & Li, F. (2026). Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity. Angewandte Chemie International Edition, 65(31). https://doi.org/10.1002/anie.5724301
Vancouver
Dang S, Sun Y, Chen L, Dong Y, Han Z, Hou J, et al. Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity. Angewandte Chemie International Edition. 2026;65(31). doi:10.1002/anie.5724301
BibTeX
@article{Dang2026,
author = {Dang, Shuangbo and Sun, Yun and Chen, Ling and Dong, Yuhang and Han, Zibo and Hou, Junwei and Wang, Xiaoshuang and Kang, Ziyao and Liu, Zhaoming and Wang, Zhuo and Li, Qiming and Ren, Jin and Li, Feng},
title = {Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {31},
doi = {10.1002/anie.5724301}
}
EUVIMED